Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidekatsu Yanai

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Cardiology Research|November 23, 2020
Metabolic Syndrome and COVID-19Hidekatsu Yanai
Journal of Clinical Medicine Research|November 14, 2015
Nutrition for SarcopeniaHidekatsu Yanai
Journal of Clinical Medicine Research|December 8, 2016
Effects of N-3 Polyunsaturated Fatty Acids on DementiaHidekatsu Yanai
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 30, 2019
[Diagnosis of Secondary Hyperlipidemia due to Diabetes]Hidekatsu Yanai
Journal of Medical Cases|April 22, 2024
Renal Function Improvement With Glucagon-Like Peptide-1 Receptor Agonist in a Patient With Type 2 DiabetesHidekatsu Yanai
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Periodic health checkups reduce the risk of hospitalization in patients with type 2 diabetesHidetaka Hamasaki, Hidekatsu Yanai
Frontiers in Clinical Diabetes and Healthcare|July 21, 2023
Association of the use of psychotropic drugs with hospitalization, cardiovascular events, and mortality in patients with type 2 diabetes: a propensity score-matched cohort studyHidetaka Hamasaki, Hidekatsu Yanai
International Journal of Molecular Sciences|March 13, 2019
Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and PerspectivesHidekatsu Yanai, Hiroshi Yoshida
Global Health & Medicine|March 10, 2021
Secondary dyslipidemia: its treatments and association with atherosclerosisHidekatsu Yanai, Hiroshi Yoshida
World Journal of Diabetes|June 22, 2011
Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetesHidekatsu Yanai, Sumie Moriyama
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Cardiology Research|November 23, 2020
Metabolic Syndrome and COVID-19Hidekatsu Yanai
Journal of Clinical Medicine Research|November 14, 2015
Nutrition for SarcopeniaHidekatsu Yanai
Journal of Clinical Medicine Research|December 8, 2016
Effects of N-3 Polyunsaturated Fatty Acids on DementiaHidekatsu Yanai
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 30, 2019
[Diagnosis of Secondary Hyperlipidemia due to Diabetes]Hidekatsu Yanai
Journal of Medical Cases|April 22, 2024
Renal Function Improvement With Glucagon-Like Peptide-1 Receptor Agonist in a Patient With Type 2 DiabetesHidekatsu Yanai
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Periodic health checkups reduce the risk of hospitalization in patients with type 2 diabetesHidetaka Hamasaki, Hidekatsu Yanai
Frontiers in Clinical Diabetes and Healthcare|July 21, 2023
Association of the use of psychotropic drugs with hospitalization, cardiovascular events, and mortality in patients with type 2 diabetes: a propensity score-matched cohort studyHidetaka Hamasaki, Hidekatsu Yanai
International Journal of Molecular Sciences|March 13, 2019
Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and PerspectivesHidekatsu Yanai, Hiroshi Yoshida
Global Health & Medicine|March 10, 2021
Secondary dyslipidemia: its treatments and association with atherosclerosisHidekatsu Yanai, Hiroshi Yoshida
World Journal of Diabetes|June 22, 2011
Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetesHidekatsu Yanai, Sumie Moriyama
Pageof 13